Experts hope the technology could reduce the need for breast cancer patients to return for extra surgery.
A new scanner, the Field Cycling Imager (FCI), developed by the University of Aberdeen, has shown promise in improving breast cancer diagnosis and treatment. Unlike traditional MRI, the FCI can vary magnetic field strengths during scans, providing more detailed images and better distinguishing between tumor and healthy tissue. This advancement could reduce the need for repeat surgeries, as it can detect cancer spread previously undetectable. A study involving nine participants, conducted with NHS Grampian, highlights the scanner's potential to enhance treatment accuracy and reduce operating theater demands. The research, published in *Nature Communications Medicine*, underscores the FCI's role in future cancer management, offering hope for more personalized and efficient care.
